PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Primacor In Dextrose 5% In Plastic Container, and what generic alternatives are available?
Primacor In Dextrose 5% In Plastic Container is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Primacor In Dextrose 5% In Plastic Container
A generic version of PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 11 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mahidol University | Phase 2 |
| Zagazig University | Phase 4 |
| University of Kansas Medical Center | Phase 1 |
See all PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-001 | Aug 9, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-004 | Aug 9, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-002 | Aug 9, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-003 | Aug 9, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-001 | Aug 9, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-003 | Aug 9, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Sanofi Aventis Us | PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 020343-002 | Aug 9, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
See the table below for patents covering PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
